Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 21/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 22/06/2018

Management Name : Miss SUJITRA SAENGDUEANCHAI | Type of securities : Common share | Methods of Acquisition / Disposition : Sell | Transaction Date : 25/06/2018

Of Details DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Company Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021   Consolidated Year 31/12/2021 DOD BIOTECH PUBLIC COMPANY LIMITED 2021 Reviewed

/ 2020. The reason for the increase revenues due to increased sales of both domestic and international. Although it has the COVIC-19 epidemic situation, but still maintain a close relationship with

At the cabinet meeting on 10 March 2020, the cabinet approved several measures in the first-phase relief package to reduce both direct and indirect impact of the COVID-19 epidemic on the economy

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

million baht or 47.3 percent. Mainly due to the overall economic slowdown from the crisis situation from the epidemic of the Covid-19 virus, resulting in a reduced advertising expenditure in print media and

the Company having increased sales of products abroad. Despite the COVIC-19 epidemic situation, the company has maintained a close relationship with overseas customers through online systems. And the

indirect impact of the COVID-19 epidemic on the economy. In a move to restore capital market confidence, the cabinet approved an additional tax privilege for people who purchase investment units in “SSF